The clinical immunology of human Chagas disease

Trends in Parasitology

Volumn 21, Issue 12, 2005, Pages 581-587

  Dutra, Walderez O ^a   Rocha, Manoel Otávio C ^a   Teixeira, Mauro M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR IMMUNITY; CHAGAS DISEASE; CLINICAL FEATURE; DISEASE SEVERITY; HEART DISEASE; HUMAN; HUMORAL IMMUNITY; IMAGING; IMMUNOLOGY; IMMUNOPATHOLOGY; LABORATORY TEST; PARASITOSIS; PATHOGENESIS; POPULATION RESEARCH; PROTOZOAL INFECTION; REVIEW; SOUTH AND CENTRAL AMERICA; STANDARDIZATION; SYSTEMATIC REVIEW; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; HUMANS; TRYPANOSOMA CRUZI;

PROTOZOA; TRYPANOSOMA CRUZI;

EID: 27644487615     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2005.09.007     Document Type: Review

References (68)

1. A. Moncayo Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries Mem. Inst. Oswaldo Cruz 98 2003 577 591
2. World Health Organization Control of Chagas disease WHO Technical Report Series 905 2002 109
3. D.A. Leiby Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors J. Infect. Dis. 176 1997 1047 1052
4. J.C. Dias The impact of Chagas disease control in Latin America: a review Mem. Inst. Oswaldo Cruz 97 2002 603 612
5. J.A. Urbina, and R. Docampo Specific chemotherapy of Chagas disease: controversies and advances Trends Parasitol. 19 2003 495 501
6. C.A. Buscaglia, and J.M. Di Noia Trypanosoma cruzi clonal diversity and the epidemiology of Chagas disease Microbes Infect. 5 2003 419 427
7. A.R. Vago Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs Am. J. Pathol. 156 2000 1805 1809
8. A.M. Macedo Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of Chagas disease Mem. Inst. Oswaldo Cruz 99 2004 1 12
9. U.G. Meneghelli Chagasic enteropathy Rev. Soc. Bras. Med. Trop. 37 2004 252 260
10. M.O. Rocha Clinical management of chronic Chagas cardiomyopathy Front. Biosci. 8 2003 e44 e54
11. S.A. Morris Pathophysiological insights into the cardiomyopathy of Chagas disease Circulation 82 1990 1900 1909
12. A.A. Perez Value of the radiological study of the thorax for diagnosing left ventricular dysfunction in Chagas disease Arq. Bras. Cardiol. 80 2003 208 213
13. W. Mosca Longitudinal study of immune response in human Chagas disease J. Clin. Microbiol. 22 1985 438 441
14. M.J. Morato Cellular immune responses of chagasic patients to antigens derived from different Trypanosoma cruzi strains and clones Am. J. Trop. Med. Hyg. 35 1986 505 511
15. R.T. Gazzinelli Two models of idiotypic stimulation of T lymphocytes from patients with Chagas disease: correlations with clinical forms of infection Res. Immunol. 140 1990 757 761
16. + B cells or activated T cells of chagasic patients, respectively Scand. J. Immunol. 51 2000 91 97
17. + T cells with the presence of Trypanosoma cruzi antigens in chronic human chagasic myocarditis Am. J. Trop. Med. Hyg. 56 1997 485 489
18. N. Nitz Heritable integration of kDNA minicircle sequences from Trypanosoma cruzi into the avian genome: insights into human Chagas disease Cell 118 2004 175 186
19. G. Levitus Humoral autoimmune response to ribosomal P proteins in chronic Chagas heart disease Clin. Exp. Immunol. 85 1991 413 417
20. P.M. Cossio In vitro interactions between lymphocytes of chagasic individuals and heart tissue Medicina (Buenos Aires) 36 1976 287 293
21. L.C. Abel Molecular mimicry between cardiac myosin and Trypanosoma cruzi antigen B13: identification of a B13-driven human T cell clone that recognizes cardiac myosin Braz. J. Med. Biol. Res. 30 1997 1305 1308
22. W.O. Dutra Activated T and B lymphocytes in peripheral blood of patients with Chagas disease Int. Immunol. 6 1994 499 506
23. C. Guerreiro, and A. Machado Da reação de Bordet e Gendou na moléstia de Carlos Chagas como elemento diagnóstico Brasil Med. 27 1913 225 226
24. R.T. Gazzinelli Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies Parasite Immunol. 13 1991 345 356
25. A. Krettli, and Z. Brener Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies J. Immunol. 128 1982 2009 2012
26. F. Cordeiro Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of human Chagas disease Clin. Diagn. Lab. Immunol. 8 2001 112 118
27. L.M. Galvao Lytic antibody titre as a means of assessing cure after treatment of Chagas disease: a 10 years follow-up study Trans. R. Soc. Trop. Med. Hyg. 87 1993 220 223
28. J.R. Cancado Long term evaluation of etiological treatment of Chagas disease with benznidazole Rev. Inst. Med. Trop. Sao Paulo 44 2002 29 37
29. R. Viotti Treatment of chronic Chagas disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up Am. Heart J. 127 1994 151 162
30. E. Borda A circulating IgG in Chagas' disease which binds to β-adrenoceptors of myocardium and modulates their activity Clin. Exp. Immunol. 57 1984 679 686
31. L. Sterin-Borda, and E. Borda Role of neurotransmitter autoantibodies in the pathogenesis of chagasic peripheral dysautonomia Ann. N. Y. Acad. Sci. 917 2000 273 280
32. R. Jahns Direct evidence for a β1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy J. Clin. Invest. 113 2004 1419 1429
33. N.J. Freedman, and R.J. Lefkowitz Anti-β(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation J. Clin. Invest. 113 2004 1379 1382
34. D.D. Reis Antibodies to Trypanosoma cruzi express idiotypic patterns that can differentiate between patients with asymptomatic or severe Chagas disease J. Immunol. 150 1993 1611 1618
35. + lymphocytes Am. J. Trop. Med. Hyg. 48 1993 637 642
36. W.O. Dutra Influence of parasite presence on the immunologic profile of peripheral blood mononuclear cells from chagasic patients after specific drug therapy Parasite Immunol. 18 1996 579 585
37. W.O. Dutra Chagasic patients lack CD28 expression on many of their circulating T lymphocytes Scand. J. Immunol. 43 1996 88 93
38. R.P. Costa T-cell repertoire analysis in acute and chronic human Chagas disease: differential frequencies of Vβ 5 expressing T cells Scand. J. Immunol. 51 2000 511 519
39. E. Cunha-Neto Restricted heterogeneity of T cell receptor variable α chain transcripts in hearts of Chagas disease cardiomyopathy patients Parasite Immunol. 16 1994 171 179
40. - cells from chagasic patients: distinct repertoire and cytokine expression Clin. Exp. Immunol. 137 2004 129 138
41. A. Talvani Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas disease J. Infect. Dis. 189 2004 214 220
42. J.A. Gomes Evidence that development of severe cardiomyopathy in human Chagas disease is due to a Th1-specific immune response Infect. Immun. 71 2003 1185 1193
43. L.C. Abel Chronic Chagas disease cardiomyopathy patients display an increased IFN-γ response to Trypanosoma cruzi infection J. Autoimmun. 17 2001 99 107
44. R.C. Ferreira Increased plasma levels of tumor necrosis factor-α in asymptomatic/'indeterminate' and Chagas disease cardiomyopathy patients Mem. Inst. Oswaldo Cruz 98 2003 407 411
45. A. Talvani Elevated concentrations of CCL2 and tumor necrosis factor-α in chagasic cardiomyopathy Clin. Infect. Dis. 38 2004 943 950
46. S.A. Laucella Frequency of interferon-γ-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease J. Infect. Dis. 189 2004 909 918
47. L.M. Bahia-Oliveira Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection 14-30 years ago J. Infect. Dis. 182 2000 634 638
48. W.O. Dutra Cytokine mRNA profile of peripheral blood mononuclear cells isolated from individuals with Trypanosoma cruzi chronic infection Scand. J. Immunol. 45 1997 74 80
49. S. de Barros-Mazon Differential regulation of lymphoproliferative responses to Trypanosoma cruzi antigen in patients with the cardiac or indeterminate form of Chagas disease Clin. Immunol. 111 2004 137 145
50. P.E. Souza Monocytes from patients with indeterminate and cardiac forms of Chagas disease display distinct phenotypic and functional characteristics associated with morbidity Infect. Immun. 72 2004 5283 5291
51. I.A. Colorado HLA class II DRB1, DQB1, DPB1 polymorphism and cardiomyopathy due to Trypanosoma cruzi chronic infection Hum. Immunol. 61 2000 320 325
52. K.C. Fae HLA and β-myosin heavy chain do not influence susceptibility to Chagas disease cardiomyopathy Microbes Infect. 2 2000 745 751
53. A. Nieto HLA haplotypes are associated with differential susceptibility to Trypanosoma cruzi infection Tissue Antigens 55 2000 195 198
54. J.E. Calzada Chemokine receptor CCR5 polymorphisms and Chagas disease cardiomyopathy Tissue Antigens 58 2001 154 158
55. M.A. Campos, and R.T. Gazzinelli Trypanosoma cruzi and its components as exogenous mediators of inflammation recognized through Toll-like receptors Mediators Inflamm. 13 2004 139 143
56. Z. Brener, and R.T. Gazzinelli Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas disease Int. Arch. Allergy Immunol. 114 1997 103 110
57. + T cells in Trypanosoma cruzi infection Immunol. Rev. 201 2004 304 317
58. J.S. Silva The role of nitric oxide in the pathogenesis of Chagas disease Front. Biosci. 1 2002 314 325
59. K.L. Cummings, and R.L. Tarleton Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice Infect. Immun. 72 2004 4081 4089
60. L.F. Umekita, and I. Mota How are antibodies involved in the protective mechanism of susceptible mice infected with T. cruzi? Braz. J. Med. Biol. Res. 33 2000 253 258
61. M.B. Soares Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism Am. J. Pathol. 159 2001 703 709
62. J.S. Silva Interleukin 10 and interferon-γ regulation of experimental Trypanosoma cruzi infection J. Exp. Med. 175 1992 169 174
63. P.S. Coelho Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes induce in vivo leukocyte recruitment dependent on MCP-1 production by IFN-γ-primed- macrophages J. Leukoc. Biol. 71 2002 837 844
64. F.S. Machado CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi J. Infect. Dis. 191 2005 627 636
65. M.M. Teixeira Chemokines, inflammation and Trypanosoma cruzi infection Trends Parasitol. 18 2002 262 265
66. J.S. Aliberti Modulation of chemokine production and inflammatory responses in IFN-γ and TNF-α receptor p55 deficient mice during Trypanosoma cruzi infection Am. J. Pathol. 158 2001 1433 1440
67. A. Talvani Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-γ as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi Microbes Infect. 2 2000 851 866
68. A.P. Marino Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis Circulation 110 2004 1443 1449